Mereo BioPharma Group plc (MREO) stock
MREONasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.29+0.01 (+5.39%)
Close on Nov 18, 2026Market cap $46.20MP/E –Yield –
Mereo BioPharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Mereo BioPharma's enterprise value was $19.03M on Nov 11, 2026, against $246.64M a year earlier. Over the last 5 years it ranged from $1.80M to $582.12M, with a median of $124.38M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $19.03M | +11.2% |
| 2025 | Dec 31, 2025 | $17.11M | -96.1% |
| 2024 | Dec 31, 2024 | $434.04M | +106.2% |
| 2023 | Dec 29, 2023 | $210.49M | +152.7% |
| 2022 | Dec 30, 2022 | $83.29M | -23.2% |
| 2021 | Dec 31, 2021 | $108.47M | +69.4% |
| 2020 | Dec 31, 2020 | $64.03M | -99.9% |
| 2019 | Dec 31, 2019 | $46.67B | +33813324.8% |
| 2018 | Apr 25, 2018 | $138.03K | +54.1% |
| 2017 | Apr 28, 2017 | $89.58K | – |
See a number that looks wrong?